Search Results - "Eigenbrod, S"

Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [(18)F]FET-PET imaging in intracranial WHO grade II and III gliomas by Jansen, Nathalie L, Schwartz, Christoph, Graute, Vera, Eigenbrod, Sabina, Lutz, Jürgen, Egensperger, Rupert, Pöpperl, Gabriele, Kretzschmar, Hans A, Cumming, Paul, Bartenstein, Peter, Tonn, Jörg-Christian, Kreth, Friedrich-Wilhelm, la Fougère, Christian, Thon, Niklas

“…Oligodendroglial components (OC) and loss of heterozygosity on chromosomes 1p and 19q (LOH 1p/19q) are associated with better outcome in patients with glioma…”
Get full text

Cerebral angiitis in four patients with chronic GVHD by Sostak, P, Padovan, C S, Eigenbrod, S, Roeber, S, Segerer, S, Schankin, C, Siegert, S, Saam, T, Theil, D, Kolb, H-J, Kretzschmar, H, Straube, A

“…There is growing evidence that GVHD affects the central nervous system (CNS). In this study, we describe the long-term follow-up of four allogeneic BM…”
Get full text

MRI and clinical syndrome in dura materrelated Creutzfeldt-Jakob disease by Meissner, B., Kallenberg, K., Sanchez-Juan, P., Ramljak, S., Krasnianski, A., Heinemann, U., Eigenbrod, S., Gelpi, E., Barsic, B., Kretzschmar, H. A., Schulz-Schaeffer, W. J., Knauth, M., Zerr, I.

“…Objective Iatrogenic Creutzfeldt-Jakob disease (iCJD) is mainly associated with dura mater (DM) grafts and administration of human growth hormones (hGH). Data…”
Get full text

PROGNOSTIC VALUE OF O-(2-[18F]FLUORETHYL)-L-TYROSINE POSITRON EMISSION TOMOGRAPHY (18FET-PET) WITHIN THE CLINICAL COURSE IN NEWLY DIAGNOSED GLIOBLASTOMA by Tonn, J. C., Suchorska, B., Jansen, N. L., Linn, J., Kretzschmar, H., Janssen, H., Eigenbrod, S., Simon, M., Popperl, G., Kreth, F. W., la Fougere, C., Weller, M.

“…BACKGROUND: Aim of this prospective longitudinal study was to identify static and dynamic O-(2-[18F]fluorethyl)-L-tyrosine PET (18FET-PET) derived imaging…”
Get full text

PO-0644 RE-IRRADIATION IN RECURRENT MALIGNANT GLIOMA – PREDICTIVE VALUE OF [18F]FET-PET by Niyazi, M, Jansen, N, Ganswindt, U, Schwarz, S.B, Geisler, J, Schnell, O, Eigenbrod, S, la Fougère, C, Belka, C

Get full text

Extramedullary multiple myeloma presenting as a pituitary mass lesion by Dimopoulou, C, Ormanns, S, Eigenbrod, S, Müller-Lisse, U, Emmerich, B, Reincke, M

“…A plasmocytoma involving the pituitary gland is an extremely rare entity, with approximately 22 cases of solitary myeloma or multiple myeloma presenting with…”
Get more information

Sphingosine Kinase and Sphingosine-1-Phosphate Regulate Migration, Endocytosis and Apoptosis of Dendritic Cells by Eigenbrod, S., Derwand, R., Jakl, V., Endres, S., Eigler, A.

“…Dendritic cells (DC) are inducers of primary immune responses and represent an attractive vector for cancer immunotherapy. Sphingosine kinase (SphK) and its…”
Get full text

RESULTS OF THE INTERNATIONAL INTERLABORATORY COMPARISON OF MGMT PROMOTER METHYLATION ANALYSIS INVOLVING TWENTY-THREE ACADEMIC CENTERS IN GERMANY, AUSTRIA AND THE NETHERLANDS by Reifenberger, G., Malzkorn, B., Acker, T., Bettstetter, M., Buslei, R., von Deimling, A., Dietmaier, W., Dubbink, H. J., Eigenbrod, S., Garvalov, B. K., Gerstenmaier, U., Giese, A., Haase, D., Hasselblatt, M., Kirches, E., Koch, A., Marienfeld, R., Mittelbronn, M., Montesinos-Rongen, M., Pagenstecher, A., Riemenschneider, M. J., Prinz, M., Romeike, B., Roos, A., Spiegl-Kreinecker, S., Schittenhelm, J., Schlegel, J., Thal, D. R., Tops, B. B. J., Weis, J., Westphal, G., Worm, K., Felsberg, J.

“…BACKGROUND: Molecular testing for MGMT promoter methylation has become of clinical importance in the diagnostic assessment of malignant gliomas since test…”
Get full text

Hot spots in dynamic18FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas by Kunz, M., Thon, N., Eigenbrod, S., Hartmann, C., Egensperger, R., Herms, J., Geisler, J., la Fougere, C., Lutz, J., Linn, J., Kreth, S., von Deimling, A., Tonn, J. C., Kretzschmar, H. A., Pöpperl, G., Kreth, F. W.

“…Molecular imaging studies have recently found inter- and intratumoral heterogeneity in World Health Organization (WHO) grade II gliomas. A correlative analysis…”
Get full text

Predominant influence of MGMT methylation in non-resectable glioblastoma after radiotherapy plus temozolomide by Thon, Niklas, Eigenbrod, Sabina, Grasbon-Frodl, Eva M, Lutz, Juergen, Kreth, Simone, Popperl, Gabriele, Belka, Claus, Kretzschmar, Hans A, Tonn, Joerg-Christian, Kreth, Friedrich W

“…BackgroundPatients with non-resectable glioblastoma generally exhibit a poor prognosis, even after radiotherapy plus concomitant and adjuvant temozolomide…”
Get full text

Isolation and Characterization of Bone Marrow-derived Progenitor Cells from Malignant Gliomas by GUO, Ke-Tai, JUERCHOTT, Kathrin, FU, Peng, SELBIG, Joachim, EIGENBROD, Sabina, TONN, Jörg-Christian, SCHICHOR, Christian

“…Malignant gliomas are highly-vascularised tumours. Neoangiogenesis is a crucial factor in the malignant behaviour of tumour and prognosis of patients. Several…”
Get full text

MGMT promoter methylation status and DNA mismatch repair genes in paired primary and recurrent glioblastoma: A translational study of the German Glioma Network by Tonn, J., Felsberg, J., Thon, N., Eigenbrod, S., Westphal, M., Schackert, G., Loeffler, M., Kreth, F., Weller, M., Reifenberger, G.

“…Abstract only…”
Get full text

665P First-in-human, phase Ia/b, dose-escalation/expansion study of KRAS G12C inhibitor BI 1823911, as monotherapy and combined with anticancer therapies, in patients (pts) with advanced or metastatic solid tumours harbouring a KRAS G12C mutation by Heymach, J., Kotecki, N., Prenen, H., Alonso, G., Lindsay, C.R., Barve, M., Thamer, C., Eigenbrod-Giese, S., Marotti, M.A., Van Lancker, G.

Get full text

Novel Molecular Stereotactic Biopsy Procedures Reveal Intratumoral Homogeneity of Loss of Heterozygosity of 1p/19q and TP sub(53) Mutations in World Health Organization Grade II Gliomas by Thon, N, Eigenbrod, S, Grasbon-Frodl, EM, Ruiter, M, Mehrkens, J H, Kreth, S, Tonn, J C, Kretzschmar, HA, Kreth, F W

“…We report a molecular stereotactic biopsy technique that combines histopathologic diagnosis with small sample size-adjusted molecular genetic analysis of…”
Get full text

102TiP A phase III randomised controlled trial of zongertinib (BI 1810631) compared with standard of care (SoC) in patients (pts) with locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) harbouring HER2 tyrosine kinase domain (TKD) mutations: Beamion LUNG-2 by Wu, Y-L., Johnson, M.L., Soo, R.A., Baktash, N., Maier, D., Eigenbrod-Giese, S., Yoshida, T.

Get full text

Field Trial Affirms Value of DETERMINE-Ing Nutrition-Related Problems of Free-Living Elderly by SPANGLER, ALICE A, EIGENBROD, JANET S

“…Older persons' responses to the self-assessing "DETERMINE Your Nutritional Health Checklist," which was developed by the Nutrition Screening Initiative, are…”
Get full text

NEUROSURGICAL TREATMENTS by Nanney, A. D., Adel, J. G., Smith, T. R., Chandler, J. P., Kimmell, K. T., Walter, K., Zacharia, B. E., Deibert, C., Malone, H. R., Sonabend, A. M., Neugut, A. I., Spencer, B., Bruce, J. N., Wang, Y., Li, S., Zhang, Z., Chen, X., You, G., Yang, P., Yan, W., Bao, Z., Yao, K., Liu, Y., Wang, L., Jiang, T., Farhoud, M. K., Ruge, M. I., Brandes, A. A., Ermani, M., Fioravanti, A., Andreoli, A., Pozzati, E., Bacci, A., Bartolini, S., Poggi, R., Crisi, G., Franceschi, E., Recinos, P. F., Grabowski, M. M., Nowacki, A. S., Thompson, N., Vogelbaum, M. A., Sun, P., Krueger, D., Liu, Z., Kohrman, M., Dagens, A. B., Rachinger, W., Kunz, M., Eigenbrod, S., Lutz, J., Tonn, J.-C., Kreth, F.-W., Duong, H. T., Chaloner, C., Bordo, G., Eisenberg, A., Rosenthal, K., Sim, M.-S., Boasberg, P., Faries, M. B., Hamid, O., Kelly, D. F., Thon, N., Simon, M., Westphal, M., Schackert, G., Nikkhah, G., Hentschel, B., Pietsch, T., Reifenberger, G., Weller, M., Ironside, S., Perry, J., Tsao, M., Mainprize, T., Keith, J., Laperrierre, N., Paszat, L., Sahgal, A., Hoover, J. M., Nwojo, M., Puffer, R., Parney, I. F., Tanaka, S., Nakada, M., Hayashi, Y., Hamada, J.-i., Lee, I. Y., Ekram, T., Jain, R., Scarpace, L., Omodon, M., Rock, J., Rosenblum, M., Kalkanis, S., Amankulor, N. M., Kim, J.-H., Tabar, V., Peck, K. K.

Get full text

MRI and clinical syndrome in dura mater-related Creutzfeldt-Jakob disease by MEISSNER, B, KALLENBERG, K, SCHULZ-SCHAEFFER, W. J, KNAUTH, M, ZERR, I, SANCHEZ-JUAN, P, RAMLJAK, S, KRASNIANSKI, A, HEINEMANN, U, EIGENBROD, S, GELPI, E, BARSIC, B, KRETZSCHMAR, H. A

“…Iatrogenic Creutzfeldt-Jakob disease (iCJD) is mainly associated with dura mater (DM) grafts and administration of human growth hormones (hGH). Data on disease…”
Get full text

Omics and Prognostic Markers by Ilhan, A., Wagner, L., Maj, M., Woehrer, A., Czech, T., Heinzl, H., Marosi, C., Base, W., Preusser, M., Jeuken, J. W., Navis, A. C., Sijben, A., Boots-Sprenger, S. H., Bleeker, F. E., Gijtenbeek, J. M., Wesseling, P., Seyed Sadr, E., Tessier, A., Seyed Sadr, M., Alshami, J., Anan, M., Sabau, C., Del Maestro, R., Agnihotri, S., Gajadhar, A., Wolf, A., Mischel, P. M., Hawkins, C., Guha, A., Guan, X., Chance, M. R., Barnholtz-Sloan, J. S., Larson, J. D., Rodriguez, F. J., Demer, A. M., Sarver, A. L., Dubac, A., Jenkins, R. B., Dupuy, A. J., Copeland, N. G., Jenkins, N. A., Taylor, M. D., Largaespada, D. A., Lusis, E. A., Stuart, J. E., Scheck, A. C., Coons, S. W., Lal, A., Perry, A., Gutmann, D. H., Adams, M. D., Cohen, M., Devine, K., Wolinsky, Y., Bambakidis, N., Selman, W., Miller, R., Sloan, A. E., Suchorska, B., Mehrkens, J. H., Eigenbrod, S., Eroes, C. A., Tonn, J. C., Kretzschmar, H. A., Kreth, F. W., Buczkowicz, P., Bartels, U., Morrison, A., Zarghooni, M., Bouffet, E., Kollmeyer, T. M., Wrensch, M., Decker, P. A., Xiao, Y., Rynearson, A. L., Fink, S., Kosel, M. L., Johnson, D. R., Lachance, D. H., Yang, P., Fridley, B. L., Wiemels, J., Wiencke, J., Zhou, Y.-H., Hess, K. R., Yu, L., Raj, V. R., Liu, L., Alfred Yung, W. K., Hutchins, L. F., Linskey, M. E., Roldan, G., Kachra, R., McIntyre, J. B., Magliocco, A., Easaw, J., Hamilton, M., Northcott, P. A., Van Meter, T., Eberhart, C.

Get full text

Assessing the pathogenicity of rare PRNP variants by comparing case and control allele frequency by Minikel, EV, Vallabh, SM, Lek, M, Estrada, KO, Samocha, KE, Sathirapongsasuti, JF, McLean, CY, Tung, JY, Yu, LPC, Gambetti, P, Blevins, J, Zhang, SL, Cohen, Y, Chen, W, Yamada, M, Hamaguchi, T, Sanjo, N, Mizusawa, H, Nakamura, Y, Kitamoto, T, Collins, SJ, Boyd, A, Will, RG, Knight, R, Ponto, C, Zerr, I, Kraus, TFJ, Eigenbrod, S, Giese, A, Calero, M, de Pedro-Cuesta, J, Haik, S, Laplanche, JL, Bouaziz-Amar, E, Brandel, JP, Capellari, S, Parchi, P, O'Donnell-Luria, AH, Karczewski, KJ, Marshall, JL, Boehnke, M, Laakso, M, Mohlke, KL, Kahler, A, Chambert, K, McCarroll, S, Sullivan, PF, Hultman, CM, Purcell, SM, Sklar, P, van der Lee, SJ, Rozemuller, A, Jansen, C, Hofman, A, Kraaij, R, van Rooij, JGJ, Ikram, MA, Uitterlinden, AG, van Duijn, CM, Daly, MJ, MacArthur, DG

Get full text